Stock IMNM IMMUNOME, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Immunome, Inc.

Equities

IMNM

US45257U1088

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
11.54 USD -3.35% Intraday chart for Immunome, Inc. -13.10% +7.85%
24/06 Immunome, Inc.(NasdaqCM:IMNM) added to S&P Biotechnology Select Industry Index CI
31/05 Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Immunome, Inc.(NasdaqCM:IMNM) added to S&P Biotechnology Select Industry Index
CI
Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target
MT
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing
MT
Immunome Completes Purchase of Antibodies From Atreca
MT
Immunome Promotes Max Rosett to Chief Financial Officer
AQ
Immunome Announces Completion of Purchase of Assets from Atreca
BU
Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc..
CI
Immunome Appoints Max Rosett as CFO
MT
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
BU
Immunome, Inc. Announces Promotion of Max Rosett to Chief Financial Officer
CI
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
BU
Immunome, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Certain Common Stock of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Certain Warrants of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Certain Stock Options of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Immunome to Present at 2024 Bank of America Healthcare Conference
BU
Immunome Appoints Kinney Horn as Chief Business Officer
BU
Immunome, Inc. Appoints Kinney Horn as Chief Business Officer
CI
Immunome, Inc. Announces Executive Changes
CI
JPMorgan Starts Immunome With Overweight Rating, $24 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMNM Stock
  4. News Immunome, Inc.